SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
197 hedge funds and large institutions have $911M invested in SANGAMO THERAPEUTICS INC in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 74 reducing their positions, and 23 closing their positions.
53% more call options, than puts
Call options by funds: $16.9M | Put options by funds: $11M
2.49% less ownership
Funds ownership: 55.46% → 52.97% (-2.5%)
3% less funds holding
Funds holding: 203 → 197 (-6)
8% less capital invested
Capital invested by funds: $994M → $911M (-$82.9M)
20% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 74
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$5.95M |
| 2 |
JP Morgan Chase
New York
|
+$4.79M |
| 3 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$4.06M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.98M |
| 5 |
Morgan Stanley
New York
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$9.61M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.52M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.21M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$5.38M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.27M |
SGMO Hedge Fund Activity: Q2 2021 in Review
197 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2021, worth a combined $911M — down 8.3% from $994M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of SGMO and 18 opened new positions — a net loss of 5 holders — while 74 trimmed existing stakes and 59 added.
The largest buyer was SG Americas Securities, adding an estimated $5.95M. The largest seller was Compagnie Lombard Odier SCmA, cutting an estimated $9.61M.
- 197 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2021, down from 203 in Q1 2021.
- Funds reported $911M of SANGAMO THERAPEUTICS INC stock for Q2 2021, down 8.3% quarter-over-quarter.
- 18 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2021 and 23 closed out, a net change of -5 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q2 2021 was SG Americas Securities, an estimated $5.95M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q2 2021 was Compagnie Lombard Odier SCmA, an estimated $9.61M sold.
Based on aggregated 13F filings for Q2 2021.